EDGAR Filing Documents for 0001837607-24-000006

Form 8-K - Current report:

SEC Accession No. 0001837607-24-000006

Filing Date

2024-03-19

Accepted

2024-03-19 16:33:07

Documents

Period of Report

2024-03-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	aeon-20240318x8k.htm iXBRL	8-K	80440
2	EX-4.1	aeon-20240318xex4d1.htm	EX-4.1	176978
3	EX-10.1	aeon-20240318xex10d1.htm	EX-10.1	237596
4	EX-10.2	aeon-20240318xex10d2.htm	EX-10.2	375191
5	EX-10.3	aeon-20240318xex10d3.htm	EX-10.3	43273
6	EX-10.4	aeon-20240318xex10d4.htm	EX-10.4	30876
7	EX-10.5	aeon-20240318xex10d5.htm	EX-10.5	34517
8	EX-10.6	aeon-20240318xex10d6.htm	EX-10.6	35500
9	EX-99.1	aeon-20240318xex99d1.htm	EX-99.1	23787
10	GRAPHIC	aeon-20240318xex4d1002.jpg	GRAPHIC	935
11	GRAPHIC	aeon-20240318xex99d1001.jpg	GRAPHIC	3801
	Complete submission text file	0001837607-24-000006.txt		1388298

Data Files

Seq	Description	Document	Type	Size
12	EX-101.SCH	aeon-20240318.xsd	EX-101.SCH	4361
13	EX-101.DEF	aeon-20240318_def.xml	EX-101.DEF	14402
14	EX-101.LAB	aeon-20240318_lab.xml	EX-101.LAB	16785
15	EX-101.PRE	aeon-20240318_pre.xml	EX-101.PRE	14790
28	EXTRACTED XBRL INSTANCE DOCUMENT	aeon-20240318x8k_htm.xml	XML	7177

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614

Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499

AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)